All of these disorders exert dramatic effects on central nervous system function and, therefore, neurological symptoms are the main clinical complications in these patients
Pancreas, Gallbladder, Kidney, and Gastrointestinal Safety Questions Approved GLP-1 and GLP-1/GIP therapies include warnings or precautions related to issues such as pancreatitis, gallbladder disease, acute kidney injury, severe gastrointestinal reactions, and hypersensitivity, depending on product labeling [12], [13]
However, Inzucchi suggested that younger patients and those without hypertension may benefit from semaglutide for stroke prevention
The authors systematically evaluated conflicting findings regarding DSIP's sleep-promoting effects, noting that while initial studies showed dramatic increases in slow-wave sleep, subsequent research produced more variable results depending on species, administration route, and baseline sleep states